Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis

Introduction: Focal segmental glomerulosclerosis (FSGS) is associated with podocyte damage resulting in cytoskeletal alterations leading to foot process effacement. Vincristine is a chemoprotective drug which alters cytoskeletal microtubules and has been used clinically to reverse FSGS. However, the...

詳細記述

書誌詳細

主要な著者:	William J. Mason, Jennifer C. Chandler, Alice M. Gage, Gideon Pomeranz, Karen L. Price, Marilina Antonelou, Scott R. Henderson, Laura Perin, Stefano Da Sacco, Alan D. Salama, David A. Long, Ruth J. Pepper
フォーマット:	Artigo
言語:	Inglês
出版事項:	Elsevier 2025-11-01
シリーズ:	Kidney International Reports
主題:	F-actin focal segmental glomerulosclerosis glomerular disease microtubules podocytes vincristine
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2468024925004942
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!